Cargando…

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro

Multidrug resistance (MDR) remains one of the major causes of suboptimal outcome following therapy in head and neck squamous cell carcinoma (HNSCC). ATP-binding cassette (ABC) transporters are overexpressed in HNSCC, which contributes to the limited effect of chemotherapeutic treatment. In addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brands, Roman C., De Donno, Francesco, Knierim, Marie Luise, Steinacker, Valentin, Hartmann, Stefan, Seher, Axel, Kübler, Alexander C., Müller-Richter, Urs D. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676536/ https://www.ncbi.nlm.nih.gov/pubmed/31452723 http://dx.doi.org/10.3892/ol.2019.10541

Ejemplares similares

Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment
por: Müller-Richter, Urs Dietmar Achim, et al.
Publicado: (2017)

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2022)

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2020)

The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy
por: Scheurer, Mario Joachim Johannes, et al.
Publicado: (2019)

An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report
por: Hartmann, Stefan, et al.
Publicado: (2014)

HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings
por: Boschert, Verena, et al.
Publicado: (2020)

Comprehensive Geriatric Assessment and Quality of Life Aspects in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Winter, Anna, et al.
Publicado: (2023)

Free Skin Grafting to Reconstruct Donor Sites after Radial Forearm Flap Harvesting: A Prospective Study with Platelet-Rich Fibrin (PRF)
por: Straub, Anton, et al.
Publicado: (2022)

Mandibular intraosseous pseudocarcinomatous hyperplasia: a case report
por: Fuchs, Andreas, et al.
Publicado: (2016)

Mammary analogue secretory carcinoma of a salivary gland of the hard palate with contralateral cervical lymph node metastases: A case report
por: Straub, Anton, et al.
Publicado: (2021)

Performance of artificial intelligence-based algorithms to predict prolonged length of stay after head and neck cancer surgery
por: Vollmer, Andreas, et al.
Publicado: (2023)

Metabolic Silencing via Methionine-Based Amino Acid Restriction in Head and Neck Cancer
por: Wünsch, Anna Chiara, et al.
Publicado: (2023)

Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases
por: Bostan, Marinela, et al.
Publicado: (2019)

Utilizing BMP-2 muteins for treatment of multiple myeloma
por: Seher, Axel, et al.
Publicado: (2017)

Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity
por: Linz, Christian, et al.
Publicado: (2021)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Identification of hub genes involved in cisplatin resistance in head and neck cancer
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent
por: Lagler, Charlotte, et al.
Publicado: (2017)

The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin
por: Bostan, Marinela, et al.
Publicado: (2020)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Medical-grade polycaprolactone scaffolds made by melt electrospinning writing for oral bone regeneration – a pilot study in vitro
por: Fuchs, A., et al.
Publicado: (2019)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

Ateriovenous subclavia-shunt for head and neck reconstruction
por: Depprich, Rita A, et al.
Publicado: (2008)

Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
por: Bostan, Marinela, et al.
Publicado: (2021)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023)

Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study
por: Winter, Anna, et al.
Publicado: (2022)

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
por: Helfenstein, Seth, et al.
Publicado: (2019)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin-Based Treatments
por: Marcu, Loredana G.
Publicado: (2013)

The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
por: Hägerström, Erik, et al.
Publicado: (2019)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

The Impact of Sphingosine Kinase-1 in Head and Neck Cancer
por: Tamashiro, Paulette M., et al.
Publicado: (2013)

The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy
por: Hagege, Anais, et al.
Publicado: (2021)

Investigation of three common centrifugation protocols for platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam: a prospective trial
por: Straub, Anton, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ss2j98m24mkek4afgv8j35osi